Abstract:Objective To investigate the impact of the pretreatment perfusion weighted imaging (PWI)-diffusion weighted imaging (DWI) mismatch on reperfusion and early neurological improvement after intravenous thrombolysis in acute ischemic stroke.Methods We retrospectively reviewed our collected clinical,laboratory,and radiologic data in patients receiving intravenous recombinant tissue plasminogen activator therapy,who had performed multimodal MRI in both pretreatment and 24 h post-treatment in our hospital..The "target mismatch" of PWI-DWI was defined as a PWI lesion that was 10 ml or more and 120％ or more of the DWI lesion,with DWI lesion less than 70 ml and PWI lesion less than 140 ml.The "smalllesion" was defined as a DWI and PWI volume both less than 10 ml.The others were termed "non-target mismatch".Reperfusion required a 30％ or greater reduction in PWI lesion volume on the 24-hour follow-up scar.The "early neurological improvement" was defined as the patients with an NIHSS score of 0 to 4 or 6-point or greater improvement at 7 days.Results Among 45 patients analyzed,19(41％) patients presented "target mismatch",of which 8 patients were treated over 4.5 h.The rate of reperfusion and early neurological improvement after thrombolysis in target mismatch group were both significantly increased comparing with non-target mismatch group( 16/19 vs 5/12,x2 =6.092,P ＜0.05 and 13/19 vs 2/12,x2 =7.888,P ＜ 0.05,respectively ),although the recanalization rate demonstrated no significant difference between two groups.The pooled OR for reperfusion was 6.4(95％ CI 1.156-35.437,P =0.034),and the pooled OR for favorable clinical response was 21.7 ( 95％ CI 2.234-210.110,P =0.008 ) in target mismatch patients.Among the target mismatch group,13/16 of patients with reperfusion had early neurological improvement,while no patients without reperfusion had neurological improvement.The rate of recanalization,reperfusion and neurological improvement after thrombolysis demonstrated no significant difference between target mismatch group treated within 4.5 h and beyond 4.5 h.Conclusion Patients with target mismatch profile before thrombolysis had a high reperfusion rate and were prone to get early neurological improvement,indicating that the evaluation of PWI-DWI mismatch may facilitate the selection of patients who may benefit from thrombolysis beyond the time window.

Assessment of Myocardial Ischemia by Myocardial Thallium-201 Washout Rate after Dipyridamole Infusion and Comparison Study with Coronary Flow Reserve

Value of Thallium-201 Myocardial Washout Rate after Dipyridamole Infusion in Screening Coronary Artery Disease

Myocardial thallium-201 washout rate in patients with coronary microvascular disease

Prognostic Value of Thallium-201 Myocardial Perfusion Single Photon Emission Computed Tomography in Aircrew with Silent Coronary Artery Disease

The clinical usefulness of phase analysis in detecting coronary artery disease using dipyridamole thallium-201-gated myocardial perfusion imaging with a cadmium-zinc-telluride camera

Correlation Between Perfusion Weighted Imaging-Diffusion Weighted Imaging Mismatch and Early Reperfusion after Intravenous Thrombolysis in Acute Ischemic Stroke

Clinical Application of 201 Tl/99Tcm-MIBI Dual-Isotope Myocardial Perfusion SPECT Imaging

Relationship between Semi-Quantitative Parameters of Thallium-201 Myocardial Perfusion Imaging and Coronary Artery Disease

A Comparative Study of Primary Angioplasty with Intravenous Thrombolysis in the Treatment of Acute Myocardial Infarction Using 99 Tc M -MIBI SPECT Imaging

A comparative study of primary coronary stenting and intravenous thrombolysis for acute myocardial infarction using 99mTc-MIBI SPECT imaging

Assessment of transient ischemic dilation index using rest and dipyridamole stress 99Tcm-sestamibi gated myocardial perfusion SPECT

Evaluation the role of myocardial perfusion of MRI and MR cine in acute coronary syndrome

Evaluation of the Therapeutic Effectiveness of Coronary Stenting for Acute Myocardial Infarction Using 99Tcm-Mibi SPECT Imaging

Therapeutic Efficacy of Primary PCI in Acute Myocardial Infarction Evaluated by SPECT

Clinical Application of 99Tcm-Tetrofosmin in Diagnosing Patients with Coronary Heart Diesase

Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols. Part II: Using high-dose dipyridamole to determine lung-to-heart ratios

Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols. Part III: Using dobutamine to determine lung-to-heart ratios, left ventricular dysfunction, and a potential viability marker

Assessing Coronary Artery Disease with Dipyridamole Technetium-99m-Tetrofosmin SPECT

Assessment of myocardial ischemia by MR first-pass perfusion imaging

Comparison of 2D-QCA, 3D-QCA and Coronary Angiography Derived FFR in Predicting Myocardial Ischemia Assessed by CZT-SPECT MPI.

Clinical Research of Myocardial Perfusion Imaging Using Adenosine Loading 201tl on Myocardial Viability in the Area of Coronary Chronic Vaseular Occlusion